Gentian Diagnostics ASA

Report Publication Announcement • Feb 14, 2020

4Q 2019 Results and preliminary annual report

4Q 2019 Results and preliminary annual report

Moss, 14 February 2020

Gentian Diagnostics AS announces its results for the 4th quarter and 2019 preliminary annual results. The highlights include:

• Record sales revenues of MNOK 14.1 in 4Q19, up from MNOK 11.1 in 4Q18, totaling a 27 % growth y/y

• Total sales revenue for the year of MNOK 48.0 representing 20 % growth compared to 2018

• Strong fCAL® turbo sales in Q4 resulting in a y/y growth of 112% driven by continued growth in kit sales and positive effect from bulk orders

• fPELA development completed. External validation ongoing

Please find the report and results presentation enclosed. The documents will also be made available on www.gentian.no.

For further information, please contact:

Hilja Ibert

CEO, Gentian Diagnostics

E-mail: hilja.ibert@gentian.no

Cell Phone: +47 919 05 242

Njaal Kind

CFO, Gentian Diagnostics

E-mail: njaal.kind@gentian.no

Cell Phone. +47 919 06 525